Hjem › Aterosklerose › Texas › Amarillo
Aterosklerose kliniske forsøg i Amarillo, TX
6 studier for Aterosklerose søger deltagere på steder i og omkring Amarillo (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.
Officiel studietekst (engelsk)
Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RekruttererFase 3
- PharmaTex Research, Amarillo
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RekruttererFase 3
- PharmaTex Research, LLC, Amarillo
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
RekruttererFase 2
- PharmaTex Research, LLC, Amarillo
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RekruttererFase 3
- Research Site, Amarillo
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
RekruttererFase 3
- PharmaTex Research LLC, Amarillo
Pelacarsen Roll-over Extension Program
RekruttererFase 3
- Pharma Tex Research, Amarillo
Aterosklerose forsøg i andre byer
- Boston, MA10 studier
- Houston, TX10 studier
- Washington, DC9 studier
- Orlando, FL8 studier
- Arlington, VA8 studier
- Hialeah, FL8 studier
- Durham, NC7 studier
- Memphis, TN7 studier
- Dallas, TX7 studier
- Miami, FL7 studier
- Las Vegas, NV7 studier
- Baltimore, MD6 studier
Andre studier i Amarillo
- Overvægt10 studier
- Hjertesvigt8 studier
- Ikke-småcellet lungecancer8 studier
- Overvægt7 studier
- Lungecancer5 studier
- Kardiovaskulær sygdom5 studier
- Blodpropper4 studier
- Atrieflimmer3 studier
- Fordøjelsessygdomme3 studier
- Colorektal kræft3 studier
- Brystkræft3 studier
Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.